Cancer, solid tumors
Showing 1 - 25 of >10,000
Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen mRNA Personalised Cancer vaccine
- (no location specified)
Jul 16, 2023
NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)
Not yet recruiting
- NSCLC
- +3 more
- YL202 should be intravenously infused
-
Chang chun, Jilin, ChinaJilin Provincial Cancer Hospital
Oct 25, 2023
Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)
Recruiting
- Refractory Solid Tumors
- Relapsed Solid Tumors
- KSX01-TCRT cell therapy
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- (no location specified)
Feb 15, 2023
Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- Solid Tumors
- Head and Neck Cancer
- SYH2051 tablets
- Intensity-Modulated Radiation Therapy (IMRT)
-
Shijiazhuang, Hebei, ChinaClinical Trials Information Group
Aug 21, 2023
Advanced Solid Tumor Trial in Guangzhou (NWY001)
Not yet recruiting
- Advanced Solid Tumor
- NWY001
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cancer
Aug 6, 2023
Advanced Solid Tumors Trial in Hangzhou (ZGGS15)
Not yet recruiting
- Advanced Solid Tumors
- ZGGS15
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 17, 2023
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
San Antonio, Texas
- +1 more
Sep 8, 2023
Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)
Recruiting
- Refractory Solid Tumors
- Eribulin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 22, 2023
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)
Recruiting
- Advanced Solid Tumor
- YL201 for Injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 21, 2023
Advanced Solid Tumors Trial in Shanghai (HRXG-K-1939, Adebrelimab)
Not yet recruiting
- Advanced Solid Tumors
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 4, 2023
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- (no location specified)
Aug 30, 2023
Advanced Solid Tumor Trial in Guangzhou (YL-17231)
Recruiting
- Advanced Solid Tumor
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 5, 2023
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)
Not yet recruiting
- Advanced Solid Tumor
- αPD1-MSLN-CAR T Cells
-
Beijing, ChinaNational Cancer Center Cancer Hospital Chinese Academy of Medica
Jul 13, 2023
Solid Tumor, Adult Trial in Shanghai (Tislelizumab, Lenvatinib, Cryoablation)
Recruiting
- Solid Tumor, Adult
- Tislelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 13, 2023
Advanced Solid Tumor Trial in Shanghai (HY-0102)
Not yet recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 19, 2023
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Recruiting
- Head and Neck Cancer
- +2 more
- questionnaires administration
-
Pavia, Pv, ItalyCNAO
Jul 7, 2023
Advanced Solid Tumor Trial in Beijing (LK101 injection)
Recruiting
- Advanced Solid Tumor
- LK101 injection
-
Beijing, Beijing, China
- +1 more
Sep 22, 2023
HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and
Not yet recruiting
- HER2+ Advanced Breast Cancer
- Other Solid Tumors
- ADCC-R-Epo-R T-cells + Trastuzumab
- +2 more
- (no location specified)
Aug 31, 2023